ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.

Jagdeep K Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.